Isidro Ferrer

Research.com Recognitions

• 2026 - Research.com Neuroscience in Spain Leader Award
• 2025 - Research.com Neuroscience in Spain Leader Award
• 2022 - Research.com Neuroscience in Spain Leader Award
• 2018 - Member of Academia Europaea

Overview

Best Publications

• Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

  Vivianna M. Van Deerlin;Patrick M A Sleiman;Maria Martinez-Lage;Maria Martinez-Lage;Alice Chen-Plotkin

  657
  Citations

• Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains

  Lydia Alvarez-Erviti;Maria C. Rodriguez-Oroz;J. Mark Cooper;Cristina Caballero

  632
  Citations

• Signaling of cell death and cell survival following focal cerebral ischemia: Life and death struggle in the penumbra

  Isidro Ferrer;Anna María Planas

  607
  Citations

• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  Irina Alafuzoff;Thomas Arzberger;Safa Al-Sarraj;Istvan Bodi

  544
  Citations

• Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

  Gabor G. Kovacs;Isidro Ferrer;Lea T. Grinberg;Lea T. Grinberg;Irina Alafuzoff

  516
  Citations

• BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

  Isidro Ferrer;Conxita Marín;Ma Jesús Rey;Teresa Ribalta

  482
  Citations

• Brain-derived neurotrophic factor in Huntington disease.

  I Ferrer;E Goutan;C Marı́n;M.J Rey

  409
  Citations

• Abeta species removal after abeta42 immunization.

  James A. R. Nicoll;James A. R. Nicoll;Edward Barton;Delphine Boche;James William Neal

  390
  Citations

• Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies

  Isidro Ferrer;Teresa Gómez-Isla;Berta Puig;M. Freixes

  387
  Citations

• Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

  Irina Alafuzoff;Paul G. Ince;Thomas Arzberger;Safa Al-Sarraj

  377
  Citations

• Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes

  I. Ferrer;E. Bernet;E. Soriano;T. Del Rio

  368
  Citations

• Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

  Angelique di Domenico;Angelique di Domenico;Giulia Carola;Giulia Carola;Carles Calatayud;Carles Calatayud;Meritxell Pons-Espinal;Meritxell Pons-Espinal

  363
  Citations

• Unexpected expression of α- and β-globin in mesencephalic dopaminergic neurons and glial cells

  Marta Biagioli;Milena Pinto;Daniela Cesselli;Marta Zaninello

  333
  Citations

• Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

  I. Ferrer;R. Blanco;M. Carmona;R. Ribera

  328
  Citations

• Neuronal induction of the immunoproteasome in Huntington's disease

  Miguel Díaz-Hernández;Félix Hernández;Ester Martín-Aparicio;Pilar Gómez-Ramos

  324
  Citations

• Huntington's disease is a four-repeat tauopathy with tau nuclear rods

  Marta Fernández-Nogales;Jorge Rubén Cabrera;María Santos-Galindo;Jeroen J. M. Hoozemans

  295
  Citations

• Age-related Changes in the Brain of the Dog

  D. Borràs;I. Ferrer;M. Pumarola

  290
  Citations

• Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.

  I Ferrer;R Blanco;M Carmona;B Puig

  288
  Citations

• Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus.

  I. Ferrer;F. Gullotta

  278
  Citations

• Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease

  F Graus;J Dalmau;F Valldeoriola;I Ferrer

  273
  Citations

• Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

  I. Ferrer;M. Barrachina;B. Puig

  262
  Citations